{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:15:36Z","timestamp":1779984936946,"version":"3.53.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["P30CA042014"],"award-info":[{"award-number":["P30CA042014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>A preliminary report from the recent phase 3 trial of benralizumab, a monoclonal antibody that binds to interleukin-5 receptor alpha (IL5R\u03b1), in patients with EoE revealed that medication use led to tissue eosinophil eradication but did not meet the clinical endpoint of symptom resolution. Here, we characterized the clinical, endoscopic, histologic, and transcriptional changes in patients with active EoE following benralizumab treatment. We retrospectively examined patients with EoE treated with benralizumab at the University of Utah (n =\u00a011) and reviewed reported clinical symptoms, circulating and tissue eosinophilia, and endoscopic and histologic scores. Gene expression profiles from available esophageal tissue from benralizumab-treated patients were compared to those from patients with remission EoE (n =\u00a05), active EoE (n =\u00a010), and controls (n =\u00a022). Benralizumab treatment resulted in partial symptom improvement and significant reduction in tissue eosinophilia, and endoscopic and histologic disease scoring (P\u2009&amp;lt;\u20090.01). Histologic score reductions were driven by eosinophil feature scores, while scores for epithelial features (basal cell hyperplasia and dilated intercellular spaces) were similar to those in active EoE. The gene signatures in benralizumab-treated patients mimicked those of active EoE (e.g. upregulation of POSTN, CDH26, CCL26, and downregulation of DSG1). RNA profiles and pathways support histologic findings of impaired epithelial function that persists despite benralizumab treatment. In conclusion, despite eosinophil eradication, patients treated with benralizumab had persistent epithelial injury at the histologic and transcriptional level. In this cohort, benralizumab therapy failed to eradicate inflammation and epithelial dysfunction showing that interleukin-5 receptor alpha blockade monotherapy is insufficient to control EoE.<\/jats:p>","DOI":"10.1093\/dote\/doae031","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T20:01:49Z","timestamp":1720641709000},"source":"Crossref","is-referenced-by-count":5,"title":["Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-8702","authenticated-orcid":false,"given":"Ashley L","family":"Pyne","sequence":"first","affiliation":[{"name":"Division of Gastroenterology , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah School of Medicine , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiko M","family":"Uchida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah School of Medicine , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Hazel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah School of Medicine , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J","family":"Stubben","sequence":"additional","affiliation":[{"name":"Cancer Bioinformatics Resource , Huntsman Cancer Institute, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah , Huntsman Cancer Institute, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8319-6042","authenticated-orcid":false,"given":"Joy W","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology , Department of Internal Medicine, , Ann Arbor, MI ,","place":["USA"]},{"name":"University of Michigan , Department of Internal Medicine, , Ann Arbor, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique D","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology , Hepatology, and Nutrition, Department of Pediatrics, , New York, NY ,","place":["USA"]},{"name":"Columbia University Vagelos College of Physicians & Surgeons and NewYork-Presbyterian Morgan Stanley Children's Hospital , Hepatology, and Nutrition, Department of Pediatrics, , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Gonsalves","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Northwestern University \u2013 Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Allen-Brady","sequence":"additional","affiliation":[{"name":"Division of Epidemiology , Department of Internal Medicine, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah , Department of Internal Medicine, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-6027","authenticated-orcid":false,"given":"Kathryn A","family":"Peterson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]},{"name":"University of Utah School of Medicine , Hepatology & Nutrition, , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Pletneva","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah School of Medicine , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"4","key":"2025011416565397700_ref1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cgh.2013.09.008","article-title":"Prevalence of eosinophilic esophagitis in the United States","volume":"12","author":"Dellon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2025011416565397700_ref2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J Clin Investig"},{"issue":"5","key":"2025011416565397700_ref3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.anai.2020.03.020","article-title":"AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis","volume":"124","author":"Hirano","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"2025011416565397700_ref4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"2025011416565397700_ref5","doi-asserted-by":"crossref","first-page":"AB210","DOI":"10.1016\/j.jaci.2021.12.688","article-title":"Dupilumab reduces biomarkers of type 2 inflammation in adult and adolescent patients with eosinophilic esophagitis: results from parts a and C of a three-part, phase 3 LIBERTY EoE TREET study","volume":"149","author":"Rothenberg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2025011416565397700_ref6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of Dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"issue":"25","key":"2025011416565397700_ref7","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"2025011416565397700_ref8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2025011416565397700_ref9","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/all.13451","article-title":"Immunological and hematological effects of IL-5(R\u03b1)-targeted therapy: an overview","volume":"73","author":"Hassani","year":"2018","journal-title":"Allergy"},{"key":"2025011416565397700_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from physiology to disease: a comprehensive review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025011416565397700_ref11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/JAA.S78049","article-title":"Benralizumab: a unique IL-5 inhibitor for severe asthma","volume":"9","author":"Tan","year":"2016","journal-title":"J Asthma Allergy"},{"key":"2025011416565397700_ref12","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(23)01239-8","article-title":"Efficacy and safety of Benralizumab in adults and adolescents with eosinophilic esophagitis: results from the 24-week double-blind period of the phase 3 Messina trial","author":"Rothenberg","year":"2023"},{"issue":"4","key":"2025011416565397700_ref13","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"2025011416565397700_ref14","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2016","journal-title":"Dis Esophagus"},{"issue":"11","key":"2025011416565397700_ref15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/PAS.0000000000001361","article-title":"Budesonide Oral suspension significantly improves eosinophilic esophagitis histology scoring system results","volume":"43","author":"Collins","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2025011416565397700_ref16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025011416565397700_ref17","first-page":"060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"2025011416565397700_ref18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","article-title":"variancePartition: interpreting drivers of variation in complex gene expression studies","volume":"17","author":"Hoffman","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"2025011416565397700_ref19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2025011416565397700_ref20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11882-015-0592-3","article-title":"The immunologic mechanisms of eosinophilic esophagitis","volume":"16","author":"Hill","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"2025011416565397700_ref21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fimmu.2013.00148","article-title":"The vitamin D receptor and T cell function","volume":"4","author":"Kongsbak","year":"2013","journal-title":"Front Immunol"},{"issue":"5","key":"2025011416565397700_ref22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2007-01-069229","article-title":"Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function","volume":"110","author":"Kubach","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2025011416565397700_ref23","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.155.10.4630","article-title":"Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule","volume":"155","author":"Mart\u00edn","year":"1995","journal-title":"J Immunol"},{"issue":"10","key":"2025011416565397700_ref24","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1136\/gutjnl-2023-330337","article-title":"Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"72","author":"Dellon","year":"2023","journal-title":"Gut"},{"issue":"2","key":"2025011416565397700_ref25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O\u2019Shea","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"2025011416565397700_ref26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of Esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"issue":"7","key":"2025011416565397700_ref27","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1172\/JCI58978","article-title":"Periostin promotes chronic allergic inflammation in response to Th2 cytokines","volume":"122","author":"Masuoka","year":"2012","journal-title":"J Clin Investig"},{"issue":"1","key":"2025011416565397700_ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaci.2019.07.049","article-title":"Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis","volume":"145","author":"Vanoni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2025011416565397700_ref29","doi-asserted-by":"crossref","first-page":"e0157376","DOI":"10.1371\/journal.pone.0157376","article-title":"JAK-STAT6 pathway inhibitors block Eotaxin-3 secretion by epithelial cells and fibroblasts from Esophageal eosinophilia patients: promising agents to improve inflammation and prevent fibrosis in EoE","volume":"11","author":"Cheng","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"2025011416565397700_ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The differential expression of IL-4 and IL-13 and its impact on type-2 immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"2025011416565397700_ref31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaci.2010.10.039","article-title":"A striking local esophageal cytokine expression profile in eosinophilic esophagitis","volume":"127","author":"Blanchard","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"2025011416565397700_ref32","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.jaip.2021.07.031","article-title":"Emerging therapies for eosinophilic gastrointestinal diseases","volume":"9","author":"Peterson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2025011416565397700_ref33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexcr.2014.08.026","article-title":"Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition","volume":"330","author":"Muir","year":"2015","journal-title":"Exp Cell Res"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/1\/doae031\/58499252\/doae031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/1\/doae031\/58499252\/doae031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:57:23Z","timestamp":1736873843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doae031\/7710644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doae031","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,7,11]]},"article-number":"doae031"}}